Filing Details
- Accession Number:
- 0001567619-18-007783
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-12 17:12:49
- Reporting Period:
- 2018-12-10
- Accepted Time:
- 2018-12-12 17:12:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581720 | Loxo Oncology Inc. | LOXO | Pharmaceutical Preparations (2834) | 462996673 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612312 | H. Joshua Bilenker | C/O Loxo Oncology, Inc. One Landmark Square, Suite 1122 Stamford CT 06901 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-10 | 10,000 | $13.67 | 174,407 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-10 | 969 | $130.58 | 173,438 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-10 | 2,001 | $132.09 | 171,437 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-10 | 2,104 | $133.00 | 169,333 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-10 | 2,049 | $134.31 | 167,284 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-10 | 2,377 | $135.04 | 164,907 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-10 | 400 | $136.48 | 164,507 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-10 | 100 | $137.39 | 164,407 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-12-11 | 10,000 | $13.67 | 174,407 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-11 | 647 | $134.63 | 173,760 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-11 | 1,153 | $135.76 | 172,607 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-11 | 3,393 | $136.79 | 169,214 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-11 | 2,407 | $137.63 | 166,807 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-11 | 1,100 | $139.05 | 165,707 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-11 | 1,200 | $140.15 | 164,507 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-11 | 100 | $140.61 | 164,407 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-12-10 | 10,000 | $0.00 | 10,000 | $13.67 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-12-11 | 10,000 | $0.00 | 10,000 | $13.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 328,514 | 2024-12-18 | No | 4 | M | Direct | |
| 318,514 | 2024-12-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 30,000 | Indirect | By Joshua H. Bilenker, ttee Joshua Bilenker 2018 GRAT, dated 06/20/2018 |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- Represents the aggregate of sales effected on the same day at different prices.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.14 to $131.00 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.48 to $132.38 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.56 to $133.54 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.91 to $134.83 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.91 to $135.41 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.09 to $136.86 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.28 to $135.19 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.30 to $136.28 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.31 to $137.30 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.32 to $138.05 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.53 to $139.40 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.59 to $140.57 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the vesting commencement date, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Billionaire Hedge Funds
